Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality?

M.P.C. Siroen; P.A.M. van Leeuwsen; R.J. Nijveldt; T. Teerlink; P.J. Wouters; G. van den Berghe

doi:10.1097/01.CCM.0000155784.59297.50

Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality?

M.P.C. Siroen, P.A.M. van Leeuwsen, R.J. Nijveldt, T. Teerlink, P.J. Wouters, G. van den Berghe

Research output: Contribution to journal › Article › Academic › peer-review

96 Citations (Scopus)

Original language	English
Pages (from-to)	504-510
Journal	Critical care medicine
Volume	33
Issue number	3
DOIs	https://doi.org/10.1097/01.CCM.0000155784.59297.50
Publication status	Published - 2005

Access to Document

10.1097/01.CCM.0000155784.59297.50

Cite this

Siroen, M. P. C., van Leeuwsen, P. A. M., Nijveldt, R. J., Teerlink, T., Wouters, P. J., & van den Berghe, G. (2005). Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality? Critical care medicine, 33(3), 504-510. https://doi.org/10.1097/01.CCM.0000155784.59297.50

@article{06599f2db4d54a208f4dfcbaa7c6bdda,

title = "Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality?",

author = "M.P.C. Siroen and {van Leeuwsen}, P.A.M. and R.J. Nijveldt and T. Teerlink and P.J. Wouters and {van den Berghe}, G.",

year = "2005",

doi = "10.1097/01.CCM.0000155784.59297.50",

language = "English",

volume = "33",

pages = "504--510",

journal = "Critical care medicine",

issn = "0090-3493",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}